Age, yr, median (IQR) | 72 (58-82) |
Sex, male | 1056 | (51.5) |
Serum creatinine level, μmol/L, median (IQR)† | 78 (62-99) |
Anticoagulant | | |
None | 1679 | (81.9) |
Warfarin | 315 | (15.4) |
Dabigatran | 16 | (0.8) |
Rivaroxaban | 4 | (0.2) |
Apixaban | 0 | |
Low-molecular-weight heparin | 35 | (1.7) |
Fondaparinux | 1 | (0.05) |
Antiplatelet | | |
None | 1516 | (74.0) |
Acetylsalicylic acid | 436 | (21.3) |
Clopidogrel | 50 | (2.4) |
Prasugrel | 1 | (0.05) |
Dual antiplatelets | 47 | (2.3) |
Combinations | | |
Antiplatelet and anticoagulant | 94 | (4.6) |
Antiplatelet or anticoagulant | 811 | (39.6) |
Bleeding site | | |
Intracerebral | 753 | (36.7) |
Subarachnoid | 460 | (22.4) |
Subdural | 750 | (36.6) |
Epidural | 1 | (0.05) |
Intraventricular | 11 | (0.5) |
≥ 1 site | 73 | (3.6) |